Abstract
Severe injection site reactions after subcutaneous administration of Sayana®: a retrospective, post-marketing analysis of WHO and Swiss spontaneous pharmacovigilance reports
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have